To generate HisMBP-SWI11-300, HisMBP-SWI1301-639, HisGST-PDS5A1-809 and HisMBP-WAPL1 constructs, the respective coding sequences were amplified by PCR and subcloned into pDONR223 vector by gateway BP reactions (Table S2). The resulting constructs were integrated by gateway LR reactions into pHMGWA or pHGGWA vectors for the His MBP- or HisGST- tagged fusions, respectively. For the heterologous expression, the constructs were transformed into the E. coli BL21 (DE3)pLysS cells and grown at 37 °C in the presence of 100 mg/l ampicillin until the OD600 of 0.6. Protein expression was induced by adding IPTG to a final concentration of 0.3 mM, and the cells were incubated at 37 °C for 3 h (HisMBP-SWI1301-639) or 18 °C overnight (HisMBP-SWI11-300, HisGST-PDS5A1-809 and HisMBP-WAPL1). All proteins were purified under native conditions by using Ni-NTA sepharose (QIAGEN) according to the manual.
For the purification of PDS5A1-809-WAPL1 heterodimers, the ampicillin resistance gene of WAPL1-pHMGWA was first replaced by the kanamycin resistance gene and co-transformed into BL21 (DE3)pLysS cells containing the vector PDS5A1-809-pHGGWA. The cells harboring both constructs were grown at 37 °C in the presence of 100 mg/l ampicillin and 50 mg/l kanamycin until the OD600 to 0.6 and induced with 0.3 mM IPTG at 18 °C for overnight. Cells were harvested and PDS5A1-809 and WAPL1 heterodimers were purified using GST agarose beads (Novogene). Coomassie Brilliant Blue (CBB) stained gels of all purified proteins used in this study are shown in Supplementary Fig. 15. The protease inhibitor cocktail (Roche) was always used in the purification procedures.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.